| 001 | 280259 | ||
| 005 | 20250831001837.0 | ||
| 024 | 7 | _ | |a 10.1186/s13195-025-01815-6 |2 doi |
| 024 | 7 | _ | |a pmid:40775365 |2 pmid |
| 024 | 7 | _ | |a altmetric:180264341 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-00937 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Lohner, Valerie |0 P:(DE-2719)2811856 |b 0 |
| 245 | _ | _ | |a Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis. |
| 260 | _ | _ | |a London |c 2025 |b BioMed Central |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1756287941_2228 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Background:Cerebral small vessel disease (CSVD) is a common neurological condition that contributes to strokes, dementia, disability, and mortality worldwide. We conducted a systematic review and meta-analysis to investigate the use of neuroimaging CSVD markers in machine learning (ML) based diagnosis and prognosis of cognitive impairment and dementia, and identify both methodological changes over time and barriers to clinical translation.Methods:Following the PRISMA guidelines, we systematically searched for original studies that used both neuroimaging CSVD markers and ML methods for diagnosing and prognosing neurodegenerative diseases (preregistration in PROSPERO: CRD42022366767). Each paper was independently reviewed by a pair of reviewers at all stages, with a third consulted to resolve conflicts. We meta-analysed the effectiveness of ML models to distinguish healthy controls from Alzheimer’s dementia and cognitive impairment, using area under the curve (AUC) as the performance metric.Results:We identified 75 studies: 43 on diagnosis, 27 on prognosis, and 5 on both. Nearly 60% of studies were published in the past two years, reflecting a growing interest in using CSVD markers in ML-based diagnosis and prognosis of neurodegenerative diseases, especially Alzheimer’s dementia. This rising interest may be linked to the strong performance of such models: according to our meta-analysis, ML approaches using CSVD markers perform well in differentiating healthy controls from Alzheimer’s dementia (AUC 0.88 [95%-CI 0.85–0.92]) and cognitive impairment (AUC 0.84 [95%-CI 0.74–0.95]). However, the growing interest has not been matched by methodological rigour: only 16 studies met the criteria for inclusion in the meta-analysis due to inconsistent reporting, only five assessed the generalisability of their models on external datasets, and six lacked clear diagnostic criteria.Conclusions:Interest in incorporating CSVD markers into ML models for neurodegenerative disease classification is on the rise, and their performance suggests that this is worth further exploration. Serious methodological issues, including inconsistent reporting, limited generalisability testing, and other potential biases, are unfortunately common and hinder further adoption. Our targeted recommendations provide a roadmap to accelerate the integration of ML into clinical practice. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Alzheimer’s dementia |2 Other |
| 650 | _ | 7 | |a Artificial intelligence |2 Other |
| 650 | _ | 7 | |a Cerebral small vessel disease |2 Other |
| 650 | _ | 7 | |a Cognitive impairment |2 Other |
| 650 | _ | 7 | |a Dementia |2 Other |
| 650 | _ | 7 | |a Machine learning |2 Other |
| 650 | _ | 7 | |a Neurodegenerative diseases |2 Other |
| 650 | _ | 7 | |a Neuroimaging |2 Other |
| 700 | 1 | _ | |a Badhwar, Amanpreet |0 0000-0003-3414-3395 |b 1 |
| 700 | 1 | _ | |a Detcheverry, Flavie E |0 0000-0002-9909-9754 |b 2 |
| 700 | 1 | _ | |a García, Cindy L |b 3 |
| 700 | 1 | _ | |a Gellersen, Helena M |0 P:(DE-2719)9002125 |b 4 |
| 700 | 1 | _ | |a Khodakarami, Zahra |b 5 |
| 700 | 1 | _ | |a Lattmann, Rene |0 P:(DE-2719)9001995 |b 6 |u dzne |
| 700 | 1 | _ | |a Li, Rui |b 7 |
| 700 | 1 | _ | |a Low, Audrey |0 0000-0002-9960-9849 |b 8 |
| 700 | 1 | _ | |a Mazo, Claudia |0 0000-0003-1703-8964 |b 9 |
| 700 | 1 | _ | |a Metz, Amelie |0 0000-0001-9104-5383 |b 10 |
| 700 | 1 | _ | |a Parent, Olivier |0 0000-0002-3177-0353 |b 11 |
| 700 | 1 | _ | |a Phillips, Veronica |0 0000-0002-4383-9434 |b 12 |
| 700 | 1 | _ | |a Saeed, Usman |b 13 |
| 700 | 1 | _ | |a Tan, Sean Y W |b 14 |
| 700 | 1 | _ | |a Tamburin, Stefano |0 0000-0002-1561-2187 |b 15 |
| 700 | 1 | _ | |a Llewellyn, David J |b 16 |
| 700 | 1 | _ | |a Rittman, Timothy |0 0000-0003-1063-6937 |b 17 |
| 700 | 1 | _ | |a Waters, Sheena |0 0000-0001-7241-2272 |b 18 |
| 700 | 1 | _ | |a Bernal, Jose |0 P:(DE-2719)9001989 |b 19 |e Last author |
| 773 | _ | _ | |a 10.1186/s13195-025-01815-6 |g Vol. 17, no. 1, p. 183 |0 PERI:(DE-600)2506521-X |n 1 |p 183 |t Alzheimer's research & therapy |v 17 |y 2025 |x 1758-9193 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937%20SUP1.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937%20SUP2.xlsx |
| 856 | 4 | _ | |x pdfa |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937%20SUP1.pdf?subformat=pdfa |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937%20SUP2.csv |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937%20SUP2.ods |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937%20SUP2.xls |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/280259/files/DZNE-2025-00937.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:280259 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)9002125 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)9001995 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 19 |6 P:(DE-2719)9001989 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-13 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-13 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ALZHEIMERS RES THER : 2022 |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-04-10T15:32:54Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-04-10T15:32:54Z |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-13 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-13 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-13 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-13 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b ALZHEIMERS RES THER : 2022 |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-13 |
| 920 | 1 | _ | |0 I:(DE-2719)5000070 |k AG Berron |l Clinical Cognitive Neuroscience |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)5000006 |k AG Düzel |l Clinical Neurophysiology and Memory |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)5000070 |
| 980 | _ | _ | |a I:(DE-2719)5000006 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::